• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Tenofovir-based PrEP for COVID-19: an untapped opportunity?基于替诺福韦的暴露前预防用药用于新型冠状病毒肺炎：一个未被发掘的机会？
AIDS. 2021 Jul 15;35(9):1509-1511. doi: 10.1097/QAD.0000000000002877.
2
Failure of pre-exposure prophylaxis with daily tenofovir/emtricitabine and the scenario of delayed HIV seroconversion.每日使用替诺福韦/恩曲他滨进行暴露前预防失败和延迟 HIV 血清转化的情况。
Int J Infect Dis. 2020 May;94:41-43. doi: 10.1016/j.ijid.2020.03.014. Epub 2020 Mar 13.
3
Updating the Adherence-Response for Oral Emtricitabine/Tenofovir Disoproxil Fumarate for Human Immunodeficiency Virus Pre-Exposure Prophylaxis Among Cisgender Women.更新口服恩曲他滨/替诺福韦二吡呋酯用于顺性别女性人类免疫缺陷病毒暴露前预防的依从性-反应。
Clin Infect Dis. 2023 May 24;76(10):1850-1853. doi: 10.1093/cid/ciad021.
4
Adherence and HIV Protection Thresholds for Emtricitabine and Tenofovir Disoproxil Fumarate Preexposure Prophylaxis among Cisgender Women: A Systematic Review.顺性别女性中恩曲他滨和富马酸替诺福韦二吡呋酯暴露前预防的依从性和 HIV 保护阈值：系统评价。
Curr HIV/AIDS Rep. 2024 Oct;21(5):264-281. doi: 10.1007/s11904-024-00705-0. Epub 2024 Aug 9.
5
On-Demand Oral Pre-exposure Prophylaxis with Tenofovir/Emtricitabine: What Every Clinician Needs to Know.按需口服替诺福韦/恩曲他滨预防：每位临床医生都需要了解的知识。
J Gen Intern Med. 2020 Apr;35(4):1285-1288. doi: 10.1007/s11606-020-05651-2. Epub 2020 Jan 21.
6
Daily and on-demand HIV pre-exposure prophylaxis with emtricitabine and tenofovir disoproxil (ANRS PREVENIR): a prospective observational cohort study.每日按需服用恩曲他滨和替诺福韦地索普西（ANRS PREVENIR）进行艾滋病毒暴露前预防：一项前瞻性观察队列研究。
Lancet HIV. 2022 Aug;9(8):e554-e562. doi: 10.1016/S2352-3018(22)00133-3. Epub 2022 Jun 27.
7
High pre-exposure prophylaxis uptake and early adherence among men who have sex with men and transgender women at risk for HIV Infection: the PrEP Brasil demonstration project.高暴露前预防药物（PrEP）的使用率和 HIV 感染风险男男性行为者和跨性别女性的早期用药依从性：PrEP Brasil 示范项目。
J Int AIDS Soc. 2017 Apr 6;20(1):21472. doi: 10.7448/IAS.20.1.21472.
8
Urine Tenofovir Levels Measured Using a Novel Immunoassay Predict Human Immunodeficiency Virus Protection.新型免疫分析法测定尿中替诺福韦水平可预测人类免疫缺陷病毒的保护作用。
Clin Infect Dis. 2021 Feb 1;72(3):486-489. doi: 10.1093/cid/ciaa785.
9
Association of age, baseline kidney function, and medication exposure with declines in creatinine clearance on pre-exposure prophylaxis: an observational cohort study.年龄、基线肾功能和药物暴露与暴露前预防中肌酐清除率下降的关联：一项观察性队列研究。
Lancet HIV. 2016 Nov;3(11):e521-e528. doi: 10.1016/S2352-3018(16)30153-9. Epub 2016 Aug 31.
10
Acceptability, safety, and patterns of use of oral tenofovir disoproxil fumarate and emtricitabine for HIV pre-exposure prophylaxis in South African adolescents: an open-label single-arm phase 2 trial.口服替诺福韦酯富马酸二吡呋酯和恩曲他滨用于南非青少年 HIV 暴露前预防的可接受性、安全性和使用模式：一项开放性、单臂 2 期临床试验。
Lancet Child Adolesc Health. 2020 Dec;4(12):875-883. doi: 10.1016/S2352-4642(20)30248-0. Epub 2020 Oct 24.

引用本文的文献

1
Effect of Tenofovir Alafenamide Fumarate on the outcomes of hospitalized COVID-19 patients: a prospective, block-balanced, open-label, randomized controlled trial.富马酸替诺福韦艾拉酚胺对住院 COVID-19 患者结局的影响：一项前瞻性、区组平衡、开放标签、随机对照临床试验。
BMC Pharmacol Toxicol. 2024 Oct 17;25(1):78. doi: 10.1186/s40360-024-00781-3.
2
Molecular modeling of some commercially available antiviral drugs and their derivatives against SARS-CoV-2 infection.针对 SARS-CoV-2 感染的一些市售抗病毒药物及其衍生物的分子建模。
Narra J. 2024 Apr;4(1):e319. doi: 10.52225/narra.v4i1.319. Epub 2024 Apr 30.
3
Tenofovir disoproxil fumarate/emtricitabine and severity of coronavirus disease 2019 in people with HIV infection.富马酸替诺福韦二吡呋酯/恩曲他滨与 HIV 感染者中 COVID-19 的严重程度。
AIDS. 2022 Dec 1;36(15):2171-2179. doi: 10.1097/QAD.0000000000003372. Epub 2022 Aug 23.
4
Druggable targets and therapeutic development for COVID-19.2019冠状病毒病的可药物化靶点与治疗开发
Front Chem. 2022 Oct 5;10:963701. doi: 10.3389/fchem.2022.963701. eCollection 2022.
5
Effect of Tenofovir Disoproxil Fumarate and Emtricitabine on nasopharyngeal SARS-CoV-2 viral load burden amongst outpatients with COVID-19: A pilot, randomized, open-label phase 2 trial.替诺福韦酯富马酸盐和恩曲他滨对COVID-19门诊患者鼻咽部严重急性呼吸综合征冠状病毒2病毒载量负担的影响：一项前瞻性、随机、开放标签的2期试验。
EClinicalMedicine. 2021 Aug;38:100993. doi: 10.1016/j.eclinm.2021.100993. Epub 2021 Jun 27.
6
Tenofovir, Another Inexpensive, Well-Known and Widely Available Old Drug Repurposed for SARS-COV-2 Infection.替诺福韦，另一种用于治疗新型冠状病毒肺炎的价格低廉、广为人知且易于获取的老药新用。
Pharmaceuticals (Basel). 2021 May 11;14(5):454. doi: 10.3390/ph14050454.

Tenofovir-based PrEP for COVID-19: an untapped opportunity?

作者信息

DeJong Colette, Spinelli Matthew A, Okochi Hideaki, Gandhi Monica

机构信息

Department of Medicine, University of California.

Division of HIV, Infectious Diseases and Global Medicine, Department of Medicine, University of California, San Francisco, USA.

出版信息

AIDS. 2021 Jul 15;35(9):1509-1511. doi: 10.1097/QAD.0000000000002877.

DOI:10.1097/QAD.0000000000002877
PMID:33710026
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8243808/
Abstract
摘要